More than a third of MS patients used cannabis in a state where it's legal

In Colorado, 38% of multiple sclerosis patients surveyed were current cannabis users, mostly for pain and sleep, reporting over 60% symptom relief with minimal side effects.

Weinkle, Laura et al.·Multiple sclerosis and related disorders·2019·Moderate EvidenceCross-Sectional
RTHC-02344Cross SectionalModerate Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
N=96

What This Study Found

38% (n=96) of MS patients were current cannabis users. Users had higher disability than non-users (PDDS=2 vs 1, p=0.02). 57% classified their use as strictly medicinal. Most common targets were pain and insomnia/poor sleep. Users reported greater than 60% benefit/relief from cannabis. Over 90% of all respondents wanted more cannabis research for MS, and 74% would consider using cannabis.

Key Numbers

38% current users (n=96). Users had higher disability (PDDS 2 vs 1, p=0.02). 57% strictly medicinal use. >60% reported benefit. 90%+ want more research. 74% would consider cannabis for MS.

How They Did This

Cross-sectional survey of MS patients at a large academic MS clinic in Colorado (where cannabis is legal recreationally and medicinally). Assessed cannabis use patterns, MS history, disability (PDDS), quality of life (PROMIS-10), and cognition (Neuro-QoL).

Why This Research Matters

MS has limited effective treatments for symptoms like pain and sleep disruption. This real-world snapshot from a legal state shows how many MS patients are using cannabis and how they rate its effectiveness.

The Bigger Picture

The finding that cannabis users had higher disability suggests that those with more severe symptoms are more likely to seek cannabis as treatment, consistent with self-medication behavior.

What This Study Doesn't Tell Us

Cross-sectional survey from a single clinic in a legal state. Self-reported data and outcomes. Selection bias likely. Cannot determine whether cannabis caused improvement or whether users simply perceive benefit.

Questions This Raises

  • ?Are MS patients in non-legal states using cannabis at similar rates through illicit channels?
  • ?Would controlled trials confirm the >60% relief reported by users?

Trust & Context

Key Stat:
38% of MS patients were cannabis users
Evidence Grade:
Single-clinic cross-sectional survey with self-reported outcomes and likely selection bias.
Study Age:
2019 survey from Colorado.
Original Title:
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
Published In:
Multiple sclerosis and related disorders, 27, 383-390 (2019)
Database ID:
RTHC-02344

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Do people with MS use cannabis?

In this Colorado survey, 38% of MS patients were current cannabis users, with 57% describing their use as strictly medicinal. Pain and insomnia were the most common reasons.

Does cannabis help with MS symptoms?

Users in this survey reported over 60% relief from symptoms, particularly pain and sleep problems, with minimal side effects. However, these are self-reported results without a control group.

Read More on RethinkTHC

Cite This Study

RTHC-02344·https://rethinkthc.com/research/RTHC-02344

APA

Weinkle, Laura; Domen, Christopher H; Shelton, Ian; Sillau, Stefan; Nair, Kavita; Alvarez, Enrique. (2019). Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.. Multiple sclerosis and related disorders, 27, 383-390. https://doi.org/10.1016/j.msard.2018.11.022

MLA

Weinkle, Laura, et al. "Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.." Multiple sclerosis and related disorders, 2019. https://doi.org/10.1016/j.msard.2018.11.022

RethinkTHC

RethinkTHC Research Database. "Exploring cannabis use by patients with multiple sclerosis i..." RTHC-02344. Retrieved from https://rethinkthc.com/research/weinkle-2019-exploring-cannabis-use-by

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.